First human clinical trial for nicotinamide riboside

Vitamin safely boosts levels of important cell metabolite linked to multiple health benefits. In the first controlled clinical trial of nicotinamide riboside (NR), a newly discovered form of Vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell metabolite that is critical for cellular energy production and protection against stress and DNA damage.

Study also identifies first biological pathway associated with risk of developing an eating disorder

Giving mice a gene mutation linked to eating disorders in people causes feeding and behavior abnormalities similar to symptoms often seen in patients with eating disorders. Only female mice are affected by the gene mutation, and some of the abnormalities they express depend on whether they are housed alone or with other mice.

UI Carver College of Medicine student receives Soozie Courter Hemophilia Scholarship awarded

University of Iowa Roy J. and Lucille A. Carver College of Medicine first-year medical student, Isaiah Reeves, is being recognized as a winner of the Soozie Courter Hemophilia Scholarship Program for his academic excellence in pursuing a higher education and sharing his inspiring story of living with hemophilia.

Potential target identified for preventing long-term effects of brain injury

More than 200,000 U.S. soldiers serving in the Middle East have experienced a blast-related traumatic brain injury, making it a common health problem and concern for that population. Traumatic brain injury (TBI) can have various harmful long-term neurological effects, including problems with vision, coordination, memory, mood, and thinking.